LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced that Hans E. Bishop has joined the Company’s Board of Directors. Mr. Bishop has had a long and distinguished career in pharmaceutical and biotechnology companies where he has led and managed business and commercial operations both in the U.S. and abroad. With the addition of Mr. Bishop, Genesis Biopharma now has eight Board members.
